Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b Dose-Ranging Study of Tofacitinib in RA
NCT00550446Phase 2Completed
- Sponsor
- Pfizer
- Start
- Sep 2007
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 2 trial of tofacitinib oral solution in rheumatoid arthritis (RA), sponsored by Pfizer. Started Sep 2007; status: completed.
02
Drugs
tofacitinib oral solution
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00550446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00550446.